[Azelastine: evaluation of the protective effects in induced bronchospasm challenges].
Marzo
C
C
Cammarata
A
A
Mazzarella
G
G
Ciampini
M
M
Bianchi
F
F
Catena
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D001986:Bronchial Spasm / Q000209:etiology / Q000517:prevention & control*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010793:Phthalazines / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012129:Respiratory Function Tests
D006634:Histamine H1 Antagonists; D010793:Phthalazines; D011724:Pyridazines; C020976:azelastine
Azelastina: valutazione degli effetti protettivi nei confronti del broncospasmo indotto.